PubRank

Howard J Weinstein

Author PubWeight™ 19.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 2006 2.58
2 Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2002 1.78
3 VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol 2002 1.76
4 Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia. Blood 2005 1.51
5 Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 2012 1.48
6 Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. Blood 2010 1.44
7 Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol 2007 1.28
8 Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial. J Clin Oncol 2005 1.15
9 Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 2004 1.05
10 Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol 2002 1.01
11 Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement. Blood 2012 0.97
12 Rituximab therapy for multisystem autoimmune diseases in pediatric patients. J Pediatr 2003 0.95
13 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-200. A five-day-old girl with leukocytosis and a worsening rash from birth. N Engl J Med 2003 0.91
14 Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leuk Lymphoma 2002 0.81
15 Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer 2013 0.75
16 The evolving standard of care for hodgkin lymphoma. J Pediatr Hematol Oncol 2008 0.75
17 Pathology quiz case 2. Diagnosis: follicular lymphoma (FL), grade 3, pediatric type. Arch Otolaryngol Head Neck Surg 2007 0.75
18 Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation. Curr Oncol Rep 2002 0.75